Skip to main content
. 2023 Nov 21;13:1219071. doi: 10.3389/fonc.2023.1219071

Figure 3.

Figure 3

Each sequence with the maximum AUC value in identifying HR+ vs. HR- (DWI600), TNBC vs. HEBC (ADC), and TNBC vs. non-TNBC (ADC) in the random training cohort. HEBC, human epidermal growth factor receptor 2 enriched BC;TNBC, triple-negative breast cancer; HR, hormone receptor. ◆ The optimal single sequence for each classification.